Tolerability Profiles of Leukotriene Receptor Antagonists and Long-Acting β2-Adrenoceptor Agonists in Combination with Inhaled Corticosteroids for Treatment of Asthma: A Review |
| |
Authors: | R. Colucci M. Fornai M. Tuccori L. Antonioli G. Pasqualetti C. Blandizzi M. Del Tacca |
| |
Affiliation: | a Interdepartmental Centre for Research in Clinical Pharmacology and Experimental Therapeutics, University of Pisa, Pisa, Italy |
| |
Abstract: | Inhaled corticosteroids, long-acting β2-adrenoceptor agonists, and leukotriene receptor antagonists are widely used for treatment of asthma. Inhaled corticosteroids are recommended as first-line therapy, whereas long-acting β2-adrenoceptor agonists and leukotriene receptor antagonists are indicated as add-on therapy in patients not adequately controlled with corticosteroids alone. A number of studies have investigated the efficacy of combinations of these drugs in asthma, but several issues concerning the safety of these treatments are highly debated. This review provides a critical appraisal of the tolerability profiles of long-acting β2-agonists and leukotriene receptor antagonists used in combination with inhaled corticosteroids for the treatment of asthma. |
| |
Keywords: | leukotriene receptor antagonists corticosteroids long-acting β2-adrenoceptor agonists asthma tolerability |
本文献已被 InformaWorld 等数据库收录! |